Analystreport

Kala Pharmaceuticals Inc (NASDAQ: KALA) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Kala Pharmaceuticals, Inc.  (KALA) 
Last kala pharmaceuticals, inc. earnings: 2/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.kalarx.com